Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | C5AR1 | P21730 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 4/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | HTR2A | P28223 | 5/20 | 0.38 |
| ▸ | HTR2C | P28335 | 5/20 | 0.38 |
| ▸ | HTR2B | P41595 | 5/20 | 0.38 |
| ▸ | PPARG | P37231 | 1/20 | 0.37 |
| ▸ | PPARA | Q07869 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5134549 | 0.96 | C5AR1 (0.50) | C5AR1TP53POLBTSHRKDM4E | |
| SCHEMBL5136199 | 0.92 | HTR2A (0.47) | C5AR1TP53POLBTSHRKDM4E | |
| SCHEMBL5137486 | 0.92 | TP53 (0.52) | C5AR1TP53POLBTSHRKDM4E | |
| SCHEMBL5150126 | 0.90 | C5AR1 (0.47) | C5AR1TP53POLBTSHRKDM4E | |
| SCHEMBL5136702 | 0.90 | C5AR1 (0.51) | C5AR1TP53POLBTSHRKDM4E | |
| SCHEMBL5137391 | 0.89 | C5AR1 (0.52) | C5AR1TP53POLBTSHRKDM4E | |
| SCHEMBL5135806 | 0.88 | C5AR1 (0.46) | C5AR1TP53POLBTSHRKDM4E | |
| SCHEMBL5135001 | 0.88 | TP53 (0.54) | C5AR1TP53POLBTSHRKDM4E | |
| SCHEMBL5136744 | 0.88 | C5AR1 (0.47) | C5AR1TP53POLBTSHRKDM4E | |
| SCHEMBL5135810 | 0.87 | C5AR1 (0.46) | C5AR1TP53POLBTSHRKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1490044-A4 | COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS | NEUROGEN CORP (US) | 2008-04-16 | — | — | EP | disclosed |
| EP-1490044-A1 | COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS | NEUROGEN CORPORATION (US) | 2004-12-29 | — | — | EP | disclosed |
| WO-2003084524-A1 | COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS | NEUROGEN CORPORATION (US) | 2003-10-16 | — | — | WO | disclosed |